Microbot Medical wins surgical robotics industry award for LIBERTY Endovascular Robotic System
Innovative start-up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit
Innovative start-up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit
Unified digital platform enables medicine price verification and grievance redressal in one place
The amendments notified under the Clinical Establishments Act, 2010 form part of this broader reform initiative aimed at creating a more responsive and facilitative regulatory ecosystem
Industry members have until 15 July 2026 to submit feedback on proposals seeking additions, deletions and modifications to the Global Tender Enquiry
As competition intensifies in the obesity treatment market, a next-generation therapy may be in development.
The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life
The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion
Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data
Partnership combines Apexon's agentic AI platforms and cloud modernization tools with AWS infrastructure to accelerate AI deployment, clinical innovation, and digital transformation across healthcare and life sciences
After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average
Subscribe To Our Newsletter & Stay Updated